Sciencell货号1801星形胶质细胞培养基AM (As

星形胶质细胞培养基是为正常人类星形胶质细胞体外培养设计的适于其生长的培养基。经灭菌的液体培养基，包含必需和非必需氨基酸、维生素、有机和无机化合物、激素、生长因子、微量矿物质和低浓度胎牛血清(2%)。该培养基缓冲体系为重碳酸盐，在含5%CO2的细胞培养箱中平衡后pH值为7.4。该培养基的配方能够选择性的促进正常人类星形胶质细胞体外培养中的增殖和生长，并为其达到理想营养平衡状态提供数量上和质量上的保证。

  星形胶质细胞培养基包含500 ml基础培养基，10ml胎牛血清(FBS,目录编号0010)，5ml星形胶质细胞生长添加物(AGS,目录编号1852)，和5 ml青霉素/链霉素溶液(P/S,目录编号0503)

1.) Pilakka-Kanthikeel S, Atluri VSR, Sagar V, Saxena SK, Nair M. (2013) "Targeted brain derived neurotropic factors (BDNF) delivery across the blood-brain barrier for neuro-protection using magnetic nano carriers: an in-vitro study." PLoS One. 8: e62241.

2.) Vijayaraghavan S, Karami A, Aeinehband S, Behbahani H, Grandien A, Nilsson B, Ekdahl KN, Lindblom RP, Piehl F, Darreh-Shori T. (2013) "Regulated Extracellular Choline Acetyltransferase Activity - The Plausible Missing Link of the Distant Action of Acetylcholine in the Cholinergic Anti-Inflammatory Pathway." PLoS One. 8: e65936

3.) Arscott W, Tandle AT, Zhao S, Shabason JE, Gordon IK, Schlaff CD, Zhang G, Tofilon PJ, Camphausen KA. (2013) 'Ionizing Radiation and Glioblastoma Exosomes: Implications in Tumor Biology and Cell Migration.'

4.) Arscott W, Tandle AT, Zhao S, Shabason JE, Gordon IK, Schlaff CD, Zhang G, Tofilon PJ, Camphausen KA. (2013) "Ionizing Radiation and Glioblastoma Exosomes: Implications in Tumor Biology and Cell Migration." Transloncol. 6: 638-48.

5.) Triscott J, Lee C, Hu K, Fotovati A, Berns R, Pambid M, Luk M, Kast RE, Kong E, Toyota E, Yip S, Toyota B, Dunn SE. (2012) "Disulfiram, a drug widely used to control alcoholism, suppresses the self-renewal of glioblastoma and over-rides resistance to temozolomide." Oncotarget. 3: 1112-23.

6.) Robinson JP, Vanbrocklin MW, Lastwika KJ, McKinney AJ, Brandner S, Holmen SL. (2010) 'Activated MEK cooperates with Ink4a/Arf loss or Akt activation to induce gliomas in vivo.'

7.) Robinson JP, Vanbrocklin MW, Lastwika KJ, McKinney AJ, Brandner S, Holmen SL. (2010) "Activated MEK cooperates with Ink4a/Arf loss or Akt activation to induce gliomas in vivo." Oncogene. 30: 1341-50.